HATTERSLEY GROUP PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: P89013 | HYDE, SK14 3EH
Showing results 451-500 of 501
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ergocalciferol | 13 | 390 | £52 | -22.3% ▼ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 13 | 168.8K | £1.8K | -70.3% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 13 | 7,800 | £121 | -43.3% ▼ |
| Chlorhexidine gluconate | 13 | 3,900 | £41 | -40.8% ▼ |
| 13 | 2,500 | £23 | -48.3% ▼ | |
| 13 | 22 | £250 | -67.4% ▼ | |
| 13 | 1,560 | £5.0K | -46.6% ▼ | |
| 13 | 390 | £1.2K | +61.2% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 12 | 336 | £49 | -65.5% ▼ |
| Labetalol hydrochloride | 12 | 812 | £140 | -47.2% ▼ |
| Aclidinium bromide | 12 | 12 | £371 | -54.8% ▼ |
| Indacaterol/glycopyrronium | 12 | 360 | £371 | -73.4% ▼ |
| Sulpiride | 12 | 1,014 | £84 | -55.2% ▼ |
| Rivastigmine | 12 | 628 | £476 | -82.6% ▼ |
| Galantamine | 12 | 336 | £334 | -68.3% ▼ |
| Ciclosporin | 12 | 672 | £580 | -28.1% ▼ |
| Exemestane | 12 | 360 | £68 | -63.1% ▼ |
| Tube feed 1.5 kcal/ml with fibre (0914011) | 12 | 252.0K | £4.7K | +3.8% ▲ |
| Methyl salicylate | 12 | 840 | £73 | +41.9% ▲ |
| Fusidic acid | 12 | 80 | £286 | +16.2% ▲ |
| Acetic acid | 12 | 65 | £61 | +3.6% ▲ |
| Terbinafine hydrochloride | 12 | 705 | £131 | -67.7% ▼ |
| Medicated stockings | 12 | 336 | £1.3K | +78.1% ▲ |
| 12 | 120 | £152 | +21.0% ▲ | |
| 12 | 133 | £886 | -41.5% ▼ | |
| 12 | 360 | £656 | +44.7% ▲ | |
| Propantheline bromide | 11 | 1,232 | £1.0K | -15.3% ▼ |
| Cinnarizine | 11 | 2,184 | £100 | -76.5% ▼ |
| Domperidone | 11 | 448 | £10 | -69.2% ▼ |
| Tapentadol | 11 | 616 | £548 | -73.3% ▼ |
| Trihexyphenidyl hydrochloride | 11 | 2,200 | £1.2K | -61.2% ▼ |
| Oxytetracycline | 11 | 1,408 | £430 | -57.4% ▼ |
| Valaciclovir | 11 | 184 | £246 | -21.7% ▼ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 11 | 77.0K | £1.7K | -11.3% ▼ |
| Olopatadine | 11 | 55 | £55 | -74.9% ▼ |
| Levobunolol hydrochloride | 11 | 660 | £209 | +51.5% ▲ |
| Fluocinolone acetonide | 11 | 660 | £88 | +1.0% vs avg |
| 11 | 55 | £67 | +5.9% ▲ | |
| 11 | 13 | £225 | -83.9% ▼ | |
| 11 | 1,980 | £1.4K | -1.1% vs avg | |
| Dexamfetamine sulfate | 10 | 1,960 | £1.6K | -72.2% ▼ |
| Dapsone | 10 | 560 | £136 | -3.2% ▼ |
| Potassium chloride | 10 | 280 | £30 | -46.5% ▼ |
| Magnesium aspartate | 10 | 208 | £187 | -34.0% ▼ |
| Sevelamer | 10 | 840 | £136 | -54.4% ▼ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 10 | 34.0K | £2.2K | +25.6% ▲ |
| Febuxostat | 10 | 280 | £22 | -73.2% ▼ |
| Dimeticone (Barrier) | 10 | 5,000 | £47 | -32.0% ▼ |
| Hepatitis A | 10 | 10 | £206 | -86.8% ▼ |
| 10 | 107 | £43 | -74.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.